Europe Glucose Monitoring Devices Market Forecast to 2030 - Regional Analysis - By Type, Application, Testing Type, and End User

List of Tables

The Europe glucose monitoring devices market is expected to grow from US$ 5,248.87 million in 2022 to US$ 12,118.27 million by 2030. It is estimated to grow at a CAGR of 11.0% from 2022 to 2030.

Growing Medical Tourism in Developing Countries Fuel Europe Glucose Monitoring Devices Market

The emerging markets in developing countries are the major factor that gives the major players a better opportunity to expand their business. These are a major reason for the market growth during the forecast period. Most market players focus on emerging markets due to the prevalence of diabetes and the increasing popularity of glucose monitoring devices in the region. In India, medical science has progressed rapidly over the past few decades. Several international patients visit India in the pursuit of incredibly affordable medical care. Moreover, Poland has slowly become a favorite medical tourism destination in Europe. For instance, in Poland, medical treatment costs are often lower by 60-80% compared to the same benefits in the rest of the EU countries. The major reason for the growth of tourism is Poland's recognition and acceptance of the European Union. The rising medical tourism in emerging nations such as Poland is anticipated to provide significant growth opportunities to the players operating in the market during the forecast period.

Europe Glucose Monitoring Devices Market Overview

The Europe glucose monitoring devices market has been segmented into the Germany, France, UK, Italy, Spain, Rest of Europe. The market growth in this region is attributed to the rising awareness of the diabetes diagnosis, increasing ageing population, and technological advancements in glucose monitoring thereby dominating the overall market growth.

Europe Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

Europe Glucose Monitoring Devices Market Segmentation

The Europe glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the Europe glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on application, the Europe glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on testing site, the Europe glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on end user, the Europe glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the Europe glucose monitoring devices market in 2022.

Based on country, the Europe glucose monitoring devices market is segmented int o the Germany, UK, France, Italy, Spain, and Rest of Europe. Germany dominated the Europe glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the Europe glucose monitoring devices market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe glucose monitoring devices market.
Highlights key business priorities to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in Europe glucose monitoring devices market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Product Code: BMIRE00029115

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe Glucose Monitoring Devices Market - Key Industry Dynamics

4.1 Key Market Drivers
- 4.1.1 Rising Incidence of Diabetes
- 4.1.2 Growing Geriatric Population
- 4.1.3 Increasing Prevalence of Obesity
4.2 Key Market Restraints
- 4.2.1 High Cost of Glucose Monitoring Devices
4.3 Key Market Opportunities
- 4.3.1 Growing Medical Tourism in Developing Countries
4.4 Future Trends
- 4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices

5. Glucose Monitoring Devices Market - Europe Market Analysis

5.1 Europe Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 - 2030

6. Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Type

6.1 Overview
6.2 Europe Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Continuous Glucose Monitoring Devices
- 6.3.1 Overview
- 6.3.2 Continuous Glucose Monitoring Devices: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.1 Sensors
    - 6.3.2.1.1 Sensors: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.2 Transmitters
    - 6.3.2.2.1 Transmitters: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.3.2.3 Receivers
    - 6.3.2.3.1 Receivers: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Self-Glucose Monitoring Devices
- 6.4.1 Overview
- 6.4.2 Self-Glucose Monitoring Devices: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.1 Testing Strips
    - 6.4.2.1.1 Testing Strips: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.2 Glucose Meters
    - 6.4.2.2.1 Glucose Meters: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.3 Lancets
    - 6.4.2.3.1 Lancets: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
  - 6.4.2.4 Others
    - 6.4.2.4.1 Others: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Application

7.1 Overview
7.2 Europe Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Type 1 Diabetes
- 7.3.1 Overview
- 7.3.2 Type 1 Diabetes: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Type 2 Diabetes
- 7.4.1 Overview
- 7.4.2 Type 2 Diabetes: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by Testing Site

8.1 Overview
8.2 Europe Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
8.3 Fingertip Testing
- 8.3.1 Overview
- 8.3.2 Fingertip Testing: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Alternate Site Testing
- 8.4.1 Overview
- 8.4.2 Alternate Site Testing: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 - by End User

9.1 Overview
9.2 Europe Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Healthcare Settings
- 9.3.1 Overview
- 9.3.2 Healthcare Settings: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Self/Homecare
- 9.4.1 Overview
- 9.4.2 Self/Homecare: Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Glucose Monitoring Devices Market - Revenue and Forecast to 2030 -Country Analysis

10.1 Europe: Glucose Monitoring Devices Market
- 10.1.1 Overview
- 10.1.2 Europe: Glucose Monitoring Devices Market, by Country
  - 10.1.2.1 Germany: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.1 Overview
    - 10.1.2.1.2 Germany: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.1.3 Germany: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.3.1 Germany: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.3.2 Germany: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.1.4 Germany: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.1.5 Germany: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.1.6 Germany: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.2 France: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.1 Overview
    - 10.1.2.2.2 France: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.2.3 France: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.3.1 France: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.3.2 France: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.2.4 France: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.2.5 France: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.2.6 France: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.3 UK: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.1 Overview
    - 10.1.2.3.2 UK: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.3.3 UK: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.3.1 UK: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.3.2 UK: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.3.4 UK: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.3.5 UK: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.3.6 UK: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.4 Italy: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.1 Overview
    - 10.1.2.4.2 Italy: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.4.3 Italy: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.4.3.1 Italy: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.4.3.2 Italy: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.4.4 Italy: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.4.5 Italy: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.4.6 Italy: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.5 Spain: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.1 Overview
    - 10.1.2.5.2 Spain: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.5.3 Spain: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.5.3.1 Spain: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.5.3.2 Spain: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.5.4 Spain: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.5.5 Spain: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.5.6 Spain: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)
  - 10.1.2.6 Rest of Europe: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.1 Overview
    - 10.1.2.6.2 Rest of Europe: Glucose Monitoring Devices Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.2.6.3 Rest of Europe: Glucose Monitoring Devices Market, by Type, 2020-2030 (US$ Million)
    - 10.1.2.6.3.1 Rest of Europe: Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.6.3.2 Rest of Europe: Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type, 2020-2030 (US$ Million)
    - 10.1.2.6.4 Rest of Europe: Glucose Monitoring Devices Market, by Application, 2020-2030 (US$ Million)
    - 10.1.2.6.5 Rest of Europe: Glucose Monitoring Devices Market, by Testing Site, 2020-2030 (US$ Million)
    - 10.1.2.6.6 Rest of Europe: Glucose Monitoring Devices Market, by End User, 2020-2030 (US$ Million)

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the Glucose Monitoring Devices Market
11.3 Organic Developments
- 11.3.1 Overview
11.1 Inorganic Developments
- 11.1.1 Overview

12. Company Profiles

12.1 B. Braun SE
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Medtronic Plc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Abbott Laboratories
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Ypsomed Holding AG
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Senseonics Holdings Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Nipro Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 GE HealthCare Technologies Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Terumo Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments

13. Appendix

13.1 About Us
13.2 Glossary of Terms